NGS-Based RNA-Seq Market to hit $7,984.90 Million by 2027 - Key Player Analysis: Pacific Biosciences of California, Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, BGI, Oxford Nanopore Technologies

NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome. The NGs based RNA seq
provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions.

In addition, this technique enables researchers to detect the known and unknown features in single assay. The report would be of an interest to various stakeholders operating in the NGS based RNA seq market. These stakeholders include manufacturing companies, dealer companies, supplier companies, wholesalers, hospitals, research centers and others.

NGS-Based RNA-Seq Industry Key Companies with their SWOT Analysis and Market Strategies

A SWOT analysis can be quite handy when it comes to determining the drivers and restraints of the NGS-Based RNA-Seq market. The NGS-Based RNA-Seq report aims to underline all the key aspects of the NGS-Based RNA-Seq market to keep you updated about the recent happenings of the market, for instance, key players and brand’s acquisitions, mergers, joint ventures, recent developments, products launches, and the competitive research.

Get Sample Copy on “NGS-Based RNA-Seq Market” at https://www.theinsightpartners.com/sample/TIPBT00002556

The List of Companies-
1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific

The increasing adoption of NGS-Based RNA-Seq is increasing due to the increasing focus of hospitals to provide better healthcare with reduced manual data entry and also to provide faster and more frequent data updates. In addition, to provide better healthcare facility, the increasing focus on care quality and patient safety is also helps to propel the growth of the market. Moreover, the rising healthcare IT initiatives also act as opportunities for the global NGS-Based RNA-Seq market over the forecast period.

The “Global NGS-Based RNA-Seq Market Analysis to 2027” is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global NGS-Based RNA-Seq market with detailed market segmentation by product & services, technology, end user and geography. The global NGS-Based RNA-Seq market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

On the basis of product & service the market is segmented into NGS-Based RNA-Seq solutions and NGS-Based RNA-Seq services. Based on technology the market is segmented into wireless technologies, hybrid technologies and wired technologies. By end user, the market is segmented into hospitals, ambulatory surgical centers, imaging & diagnostic centers and homecare settings.

Buy this report now at https://www.theinsightpartners.com/buy/TIPBT00002556

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Healthcare IT, Biotechnology and Medical Device industries.

Contact us -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com

This release was published on openPR.